
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
Infant Milk Formula Does Not Reduce Risk of Eczema and Allergies, Research Shows

09 Mar 2016 --- A special type of infant formula does not reduce allergy risk – despite previous claims to the contrary – according to British research led by Imperial College London.
The study, published in the British Medical Journal (BMJ), reviewed data from 37 different trials into hydrolyzed milk formula - a type of infant formula treated with heat to break down the milk proteins. The idea is that giving this formula to children at risk of conditions such as milk allergy and eczema, instead of standard formula, can reduce the chance of infants developing the conditions.
However, the new research showed there was no statistically significant reduction in risk of these conditions amongst babies using hydrolyzed formula. The paper also revealed conflicts of interest in many of the studies - due to financial links with infant formula manufacturers.
She says further studies into infant milk formula must be more robust. “We need to ensure future studies are carefully designed, so that our guidance to parents is based on reliable evidence.”
The trials compared hydrolyzed formula to standard formula, and some trials made comparisons with breast milk or between two different hydrolyzed formulas.
See more of our coverage in
your Google search results
Upcoming webinars

The future of infant nutrition: From science to success
Valio

From tiny guts to big impact: the powerful potential of probiotics in children’s health
Novonesis

Inside GLP-1 lives: real consumer insights to inspire innovation
FrieslandCampina Ingredients










